GT Medical Technologies, an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2 Canadian-issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Pulmonx is the global leader in interventional procedures for the treatment of COPD. It develops and markets non-surgical technologies for the assessment and treatment of patients with severe emphysema, a progressive and life-threatening form of COPD. The Pulmonx solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The technology is supported by a compelling body of clinical evidence including over 100 published scientific articles regarding the clinical benefits of Zephyr Valves. FDA granted the Zephyr Valve a ‘breakthrough device’ designation, and in June 2018 Pulmonx received FDA pre-market approval to commercialize our Zephyr Valve. The Zephyr Valve is now commercially available and physicians in more than 25 countries around the world routinely use the Zephyr Valves to improve the lives of patients with severe emphysema, with over 76,000 valves used to treat more than 19,000 patients worldwide to date.

Delta-Fly Pharma, Inc. engages in the manufacturing, sale, research and development of pharmaceutical products for cancer treatment. It also provides module technology for motorcars, telepone, oncology drug discovery, treating metastatic ovarian cancer with DFP-10825, liposome-conjugated RNAi molecule and others. The company was founded by Kiyoshi Eshima on December 6, 2010 and is headquartered in Tokushima, Japan.

Wuhan Yourui Technology Co., Ltd., established on 2012-03-08, Business scope includes research and development of computer software and hardware,Sales;electronic product,optical products,Instrumentation,Sales of Physical Equipment;Class II6826Physiotherapy and Rehabilitation Equipment,6825Research and development of medical high-frequency equipment,Production(branch only)and service(Operate within the approved period with the license);Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Orbital Therapy is a medical device company dedicated to the development of products for the treatment of breast cancer.Early detection is leading to longer survival and is shifting focus to long term effects associated with conventional treatment techniques. Medical practitioners have initiated protocols to find a way to better isolate the breast tissue from the rest of the body to reduce these long-term complications as well as deliver a higher, more precise treatment to the tumor bed, and in less time.

Hill-Rom Services, Inc., a subsidiary of Baxter International, Inc., is an American company that manufactures and sells hospital beds, furniture and health care equipment.

Hunan Kroc Pharmaceutical Co., Ltd., established on 2020-09-23, Business scope includes medical academic promotion services;medical consultation;Chemical raw material medicine technology,Chemical preparation technology,Development of Biopharmaceutical Technology;Technology transfer of chemical drug raw materials;Chemical preparation technology transfer;Biopharmaceutical technology transfer;Application and Promotion of Diabetes Intervention Technology;High-tech service;Sub-health intervention technology promotion;Biotechnology Extension Services;Medical device technology promotion service;New material technology promotion service;Class I medical device,Class II medical device,Sales of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Part of Becton, Dickinson & Co., CareFusion 2200, Inc. is an American company located in San Diego, CA, focused on medical, dental, and hospital equipment and supplies.

Maruho Co., Ltd. engages in the research, development, manufacture, and marketing of pharmaceutical products. It specializes in the production of dermatology and topical drugs. Its products include Hirudoid Cream, Eksalb, Rozex Gel, Casal Cream, Farom Tablets, and Telgin G Dry Syrup. The company was founded by Eikuma Koba in July 1915 and is headquartered in Osaka, Japan.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Gachon University Gil Medical Center is a South Korean private company. The firm operates as medical center.

Henan Provincial Peoples Hospital is a Chinese private company located in Zhengzhou. The firm operates as an hospital.

Dynatherm Medical, Inc. offers solutions for treating and preventing hypothermia in surgical patients. It offers vitalHEAT vH2, a temperature management system that warms the core organs of hypothermic patients and is used in post-surgical recovery/PACU, trauma and emergency medicine, and burn units. The company was founded in 2002 and is headquartered in Fremont, California. Dynatherm Medical, Inc. is a former subsidiary of Kobayashi Pharmaceutical Co., Ltd.

Koken Co., Ltd. is a company headquartered in Tokyo, Japan, that develops and manufactures silicone materials. It was founded in 1959 by Taichiro Akiyama.

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.